www.dexcare.com/Enterprise Software / Business OperationsFounded: 2016Funding to Date: $584MM
DexCare, founded in 2020, is a digital health company aiming to optimize health system capacity through data-driven solutions. The company's mission is to create seamless, personalized healthcare experiences by intelligently allocating health system resources. DexCare's platform seeks to integrate with healthcare providers' existing systems to manage patient demand, service line growth, and care delivery. The company is based in Seattle, Washington.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/23/2023 | Series C-1 | $15MM | $xx.xx | $430.46MM | Define Ventures, Frist Cressey Ventures, Iconiq Growth, Kaiser Permanente Ventures, Springrock Ventures, Transformation Capital | |
Price per Share
$xx.xx
Shares Outstanding
8,154,922
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Define Ventures, Frist Cressey Ventures, Iconiq Growth, Kaiser Permanente Ventures, Springrock Ventures, Transformation Capital
|
||||||
06/23/2023 | Series C | $60MM | $xx.xx | $430.46MM | Define Ventures, Frist Cressey Ventures, Iconiq Growth, Kaiser Permanente Ventures, Springrock Ventures, Transformation Capital | |
Price per Share
$xx.xx
Shares Outstanding
26,095,806
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Define Ventures, Frist Cressey Ventures, Iconiq Growth, Kaiser Permanente Ventures, Springrock Ventures, Transformation Capital
|
||||||
01/13/2022 | Series B | $50MM | $xx.xx | $211.09MM | Define Ventures, Frist Cressey Ventures, Kaiser Permanente Ventures, Providence Ventures, Springrock Ventures, Transformation Capital | |
Price per Share
$xx.xx
Shares Outstanding
34,040,231
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Define Ventures, Frist Cressey Ventures, Kaiser Permanente Ventures, Providence Ventures, Springrock Ventures, Transformation Capital
|
||||||
03/22/2021 | Series A | $21MM | $xx.xx | $52.5MM | Define Ventures, Frist Cressey Ventures, Kaiser Permanente Ventures, Providence Ventures, Springrock Ventures | |
Price per Share
$xx.xx
Shares Outstanding
37,815,348
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Define Ventures, Frist Cressey Ventures, Kaiser Permanente Ventures, Providence Ventures, Springrock Ventures
|